Join our webinar on July 24-25 for an in-depth analysis of Union Budget 2024. Learn about tax proposals, sector impacts, and investment insights. Register now!
Join CA Sachin Jain for a live course on Input Tax Credit from a litigation perspective. Gain practical insights and master ITC complexities. Register now!
The problem is confronted in cases where one of the bulk drug of the formulation has a DEPB rate whereas the other constituent bulk drug is not having any rate. The issue of calculation of DEPB rate in respect of formulations consisting of more than one bulk drug was raised in various Open Houses. It has therefore been decided to issue a clarification on the manner in which the DEPB rate is to be calculated.
